Samvad acts on $4m pre-Series A Saama Cap infusion into Wellthy Therapeutics

Mumbai-based digital therapeutics startup Wellthy Therapeutics said it has raised $4 million (around ₹30 crore) from Saama Capital, as part of its Pre-Series A round, for a 16% stake in the company.

Mint

Samvad Partners advised Saama Capital led by a team of partner Nivedita Nivargi, senior associate Lakshmi Kishore and associate Vineetha Stephen.

2020-04-01

Deal value: USD 4 Million

{incomplete}

Comments

No comments yet.